Total Funding
38
59
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
195482
Lisapharma is mainly active in the production and development of sterile injectable drugs.
Giovanni Mariani: Chief Executive Officer- Fabiana Ippolito: Chief Marketing Officer & Business Development Manager
About the Company
Since 1925 Lisapharma is mainly active in the production and development of sterile injectable drugs and it plays an important role in more than 40 countries worldwide. In July 2015 the company has been acquired by ARCADIA SGR and FUTURIMPRESA SGR, two Italian private equity funds.
The manufacturing site, based in Erba (Como, Italy), is fully
compliant with the GMP requirements both in Italy and in a broad number of international markets where the company generates most of its turnover. The company not only owns a number of Marketing Authorizations in Italy and abroad, for products which are manufactured internally, but its production facility acts as a contract manufacturer for Italian and multinational companies.
